Gastrointestinal Infection Testing Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Gastrointestinal Infection (GI) Stool Testing Market Report is Segmented by Product Type (Instrument and Reagent), Test Type (Occult Blood Test, Ova and Parasites Test, Bacteria Test, Fecal Biomarkers Test, and Other Test Types), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Market Size and Forecasts are Provided in Terms of Value (USD) for all the Above Segments.

Gastrointestinal Infection Testing Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

GI Stool Testing Market Size

GI Stool Testing Market Summary
Study Period 2021 - 2030
Market Size (2025) USD 540.71 Million
Market Size (2030) USD 742.21 Million
CAGR (2025 - 2030) 6.54 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration Low

Major Players

GI Stool Testing Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of GI Stool Testing Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

GI Stool Testing Market Analysis

The GI Stool Testing Market size is estimated at USD 540.71 million in 2025, and is expected to reach USD 742.21 million by 2030, at a CAGR of 6.54% during the forecast period (2025-2030).

Factors such as the growing burden of gastrointestinal diseases and rising preference for point-of-care tests are boosting the market growth.

In recent years, the rate of diagnosis for gastrointestinal infections has increased, propelling the market's growth. For instance, according to a report published by the Bower Cancer UK in February 2024 showed that bowel cancer is the fourth most common cancer, and approximately 43,000 people are diagnosed with bowel cancer every year in the United Kingdom. This is expected to increase the demand for stool DNA testing, which is used to screen for colon cancer in people with no symptoms, propelling the market growth.

Additionally, according to a report published by the Cureus Journal in January 2024, globally, hemorrhoids affect approximately 50% to 85% of the population, impacting individuals of all genders and across all age groups. Moreover, the report mentioned that in Northwest Ethiopia, 13.1% of patients visiting the surgical outpatient department were affected by hemorrhoids. The risk of having hemorrhoids was shown to be higher in people who were overweight and had constipation problems. Thus, the high prevalence of hemorrhoids among the population is anticipated to increase the need for a fecal occult blood test to detect the disease and hence boost the market growth early.

Also, the rising product launches increase the availability of stool testing kits and products in the market, which is anticipated to fuel market growth. For instance, in June 2022, Prenetics Group Limited, one of the global leaders in genomic and diagnostic testing, launched a novel, non-invasive, at-home screening test, ColoClear by Circle (ColoClear), for detecting early signs of colorectal cancer in Hong Kong.

Therefore, the market is expected to grow during the forecast period due to the high burden of gastric cancer and other related diseases. However, the high cost of instruments is expected to impede the growth of the GI stool testing market during the forecast period.

GI Stool Testing Industry Overview

The GI stool testing market is fragmented in nature, with the presence of major players in the market. Collaborations, mergers, and acquisitions by companies related to GI stool testing are expected to boost market growth. Some of the companies which are currently dominating the GI stool testing market are bioMérieux SA, DiaSorin SpA, Cenegenics Corporation, Abbott Laboratories, Epitope Diagnostics Inc., Genova Diagnostics, Danaher Corporation (Beckman Coulter Inc.), ScheBo Biotech AG, CTKBiotech Inc. Inc., and Cardinal Health.

GI Stool Testing Market Leaders

  1. Abbott Laboratories

  2. Genova Diagnostics

  3. bioMérieux SA

  4. Cardinal Health

  5. Danaher Corporation (Beckman Coulter, Inc.)

  6. *Disclaimer: Major Players sorted in no particular order
GI Stool Testing Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

GI Stool Testing Market News

  • June 2024: QIAGEN launched its QIAstat-Dx Gastrointestinal Panel 2 in the United States. The panel leverages QIAstat-Dx’s ability to quickly multiply many genetic targets using real-time PCR technology in the same reaction, an important advance compared to traditional microbiological testing, which often requires samples to be incubated for at least 24 hours and up to 10 days of specimen collection.
  • January 2024: ELITechGroup launched its GI Bacterial PLUS ELITe MGB Kit. It is tailored specifically for diagnosing gastrointestinal bacterial infections, the in vitro assay exclusively targets major bacterial pathogens, including Campylobacter spp., Clostridium difficile, Salmonella spp., Shigella spp., and Yersinia enterocolitica.

GI Stool Testing Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Burden of Gastrointestinal Diseases
    • 4.2.2 Rising Preference of Point of Care Test
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Instruments
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD)

  • 5.1 By Product Type
    • 5.1.1 Instruments
    • 5.1.2 Reagents
  • 5.2 By Test Type
    • 5.2.1 Occult Blood Test
    • 5.2.2 Ova and Parasites Test
    • 5.2.3 Bacteria Test
    • 5.2.4 Fecal Biomarkers Test
    • 5.2.5 Other Test Types
  • 5.3 Geography
    • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
    • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 Danaher Corporation (Beckman Coulter Inc.)
    • 6.1.3 bioMerieux SA
    • 6.1.4 Cardinal Health
    • 6.1.5 Cenogenics Corporation
    • 6.1.6 CTK Biotech Inc.
    • 6.1.7 Genova Diagnostics
    • 6.1.8 Epitope Diagnostics Inc.
    • 6.1.9 ScheBo Biotech AG
    • 6.1.10 Meridian Bioscience Inc.
    • 6.1.11 DiaSorin S.p.A.
    • 6.1.12 Quest Diagnostics Incorporated
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

GI Stool Testing Industry Segmentation

As per the scope of the report, gastrointestinal infection testing involves the detection and analysis of any pathogens in the digestive tract using the stool as a sample. The gastrointestinal infection testing market is segmented by product type, test type, and geography. The product type segment is further segmented into instrument and reagent. The test type segment is further divided into occult blood test, ova and parasites test, bacteria test, fecal biomarkers test, and other test types. By geography, the market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and South America. The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD) for the above segments.

By Product Type Instruments
Reagents
By Test Type Occult Blood Test
Ova and Parasites Test
Bacteria Test
Fecal Biomarkers Test
Other Test Types
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

GI Stool Testing Market Research FAQs

How big is the GI Stool Testing Market?

The GI Stool Testing Market size is expected to reach USD 540.71 million in 2025 and grow at a CAGR of 6.54% to reach USD 742.21 million by 2030.

What is the current GI Stool Testing Market size?

In 2025, the GI Stool Testing Market size is expected to reach USD 540.71 million.

Who are the key players in GI Stool Testing Market?

Abbott Laboratories, Genova Diagnostics, bioMérieux SA, Cardinal Health and Danaher Corporation (Beckman Coulter, Inc.) are the major companies operating in the GI Stool Testing Market.

Which is the fastest growing region in GI Stool Testing Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in GI Stool Testing Market?

In 2025, the North America accounts for the largest market share in GI Stool Testing Market.

What years does this GI Stool Testing Market cover, and what was the market size in 2024?

In 2024, the GI Stool Testing Market size was estimated at USD 505.35 million. The report covers the GI Stool Testing Market historical market size for years: 2021, 2022, 2023 and 2024. The report also forecasts the GI Stool Testing Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

GI Stool Testing Industry Report

Statistics for the 2025 GI Stool Testing market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. GI Stool Testing analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.

GI Stool Testing Market Report Snapshots